A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Phase 1 / Phase 2	2026-07-09		NCT07174583

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
IDEAYA Biosciences	12

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Columbia University Medical Center - Herbert Irving Pavilion	New York	United States	6
Fort Wayne Medical Oncology and Hematology, Inc. - Fort Wayne North Office	Fort Wayne	United States	1
NEXT Oncology Dallas	Irving	United States	9
NEXT Oncology Virginia	Fairfax	United States	40
Oncology Consultants, PA- Houston	Houston	United States	1
Sarah Cannon Research Institute - Oncology Partners	Nashville	United States	4
Sarah Cannon Research Institute at Florida Cancer Specialists	Orlando	United States	11
Sarah Cannon Research Institute at HealthOne	Denver	United States	34
Sidney Kimmel Cancer Center at Thomas Jefferson University	Philadelphia	United States	23
START Midwest	Grand Rapids	United States	79
Swedish Cancer Institute	Seattle	United States	67
The Cancer and Hematology Centers	Grand Rapids	United States	4
The University of Texas MD Anderson Cancer Center	Houston	United States	3